FDA MedWatch - TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) by Allergan: Recall - Due to Out of Sequence Capsules

If your email program has trouble displaying this email, view it as a web page
 
U.S. Food and Drug Administration Header

MedWatch - The FDA Safety Information and Adverse Event Reporting Program

A new MedWatch Safety Alert:TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) by Allergan: Recall - Due to Out of Sequence Capsules intended for: Patient, Pharmacy, Health Professional was just added to the FDA MedWatch Webpage.
 
You can read the complete MedWatch Safety Alert that includes recommendations at: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm609064.htm
 
 

U.S. Food and Drug Administration
10903 New Hampshire Avenue, Silver Spring, MD 20993
1-888-INFO-FDA (1-888-463-6332)
Privacy Policy | www.fda.gov
Manage Preferences or Unsubscribe from this List | Unsubscribe from all Email Lists

Comments

Popular Posts

Fwd: Claim "Climate law & governance" for your profile

Commissions Successfully

We have Your e-Wallet ready. Claim in 3hrs

Beneficiary countersignature modification

The State Department requires proof that you are the owner.

Your order requires immediate confirmation.

January 3nd Nоte (Оpen Up)

You’re four weeks away from more followers 📱

Reduced Payment!.